Morgan C, Saha S
Int J Angiol. 2024; 33(2):71-75.
PMID: 38846993
PMC: 11152623.
DOI: 10.1055/s-0044-1782603.
Barbieri G, Cassioli G, Kura A, Orsi R, Magi A, Berteotti M
J Clin Lab Anal. 2024; 38(5):e24998.
PMID: 38444303
PMC: 10959181.
DOI: 10.1002/jcla.24998.
Miao Z, Wang Z, Zheng S, Wang S, Miao C
Stroke Vasc Neurol. 2024; 9(5):467-480.
PMID: 38286483
PMC: 11732845.
DOI: 10.1136/svn-2023-002883.
Dai W, Zhang H, Lund H, Zhang Z, Castleberry M, Rodriguez M
Science. 2023; 381(6661):eadh5207.
PMID: 37651538
PMC: 10697821.
DOI: 10.1126/science.adh5207.
Babenko V, Fedulova K, Silachev D, Rahimi-Moghaddam P, Kalyuzhnaya Y, Demyanenko S
J Pers Med. 2023; 13(7).
PMID: 37511788
PMC: 10381732.
DOI: 10.3390/jpm13071175.
Antioxidant role of methionine-containing intra- and extracellular proteins.
Rosenfeld M, Yurina L, Vasilyeva A
Biophys Rev. 2023; 15(3):367-383.
PMID: 37396452
PMC: 10310685.
DOI: 10.1007/s12551-023-01056-7.
Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier.
Diaz A, Woo Y, Martin-Jimenez C, Merino P, Torre E, Yepes M
J Cereb Blood Flow Metab. 2021; 42(4):667-682.
PMID: 34796748
PMC: 9051146.
DOI: 10.1177/0271678X211060395.
Roles of the tissue-type plasminogen activator in immune response.
Seillier C, Helie P, Petit G, Vivien D, Clemente D, Le Mauff B
Cell Immunol. 2021; 371:104451.
PMID: 34781155
PMC: 8577548.
DOI: 10.1016/j.cellimm.2021.104451.
Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke.
Yang S, Liu R
Transl Stroke Res. 2021; 12(6):937-945.
PMID: 34224106
PMC: 8557134.
DOI: 10.1007/s12975-021-00916-2.
Recombinant Expression of Thrombolytic Agent Reteplase in Marine Microalga (Chlorodendrales, Chlorophyta).
Wu C, Zheng C, Wang J, Jiang P
Mar Drugs. 2021; 19(6).
PMID: 34071669
PMC: 8230124.
DOI: 10.3390/md19060315.
When recombinant proteins can replace rare red cells in immunohematology workups.
Flegel W, Srivastava K
Transfusion. 2021; 61(7):2204-2212.
PMID: 34060094
PMC: 9102641.
DOI: 10.1111/trf.16507.
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.
Yepes M, Woo Y, Martin-Jimenez C
Int J Mol Sci. 2021; 22(9).
PMID: 33922229
PMC: 8122722.
DOI: 10.3390/ijms22094380.
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.
Bharadwaj A, Holloway R, Miller V, Waisman D
Cancers (Basel). 2021; 13(8).
PMID: 33921488
PMC: 8070608.
DOI: 10.3390/cancers13081838.
Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer.
Piperigkou Z, Kyriakopoulou K, Koutsakis C, Mastronikolis S, Karamanos N
Cancers (Basel). 2021; 13(6).
PMID: 33809973
PMC: 8005147.
DOI: 10.3390/cancers13061441.
Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.
Beladi R, Varkoly K, Schutz L, Zhang L, Yaron J, Guo Q
Curr Neuropharmacol. 2021; 19(11):1835-1854.
PMID: 33632104
PMC: 9185782.
DOI: 10.2174/1570159X19666210225154835.
Development and Testing of Thrombolytics in Stroke.
Nikitin D, Choi S, Mican J, Toul M, Ryu W, Damborsky J
J Stroke. 2021; 23(1):12-36.
PMID: 33600700
PMC: 7900387.
DOI: 10.5853/jos.2020.03349.
Tenecteplase Thrombolysis for Acute Ischemic Stroke.
Warach S, Dula A, Milling Jr T
Stroke. 2020; 51(11):3440-3451.
PMID: 33045929
PMC: 7606819.
DOI: 10.1161/STROKEAHA.120.029749.
Impact of Polytrauma and Acute Respiratory Distress Syndrome on Markers of Fibrinolysis: A Prospective Pilot Study.
Negrin L, Dedeyan M, Plesser S, Hajdu S
Front Med (Lausanne). 2020; 7:194.
PMID: 32582720
PMC: 7280477.
DOI: 10.3389/fmed.2020.00194.
NF-κB and tPA Signaling in Kidney and Other Diseases.
White S, Lin L, Hu K
Cells. 2020; 9(6).
PMID: 32485860
PMC: 7348801.
DOI: 10.3390/cells9061348.
Improvement of Soluble Production of Reteplase in by Optimization of Chemical Chaperones in Lysis Buffer.
Fazeli B, Akbari V, Barkhordari A, Mohammad Sadeghi H
Adv Biomed Res. 2019; 8:65.
PMID: 31737582
PMC: 6839271.
DOI: 10.4103/abr.abr_212_18.
